Sign up for your FREE personalized newsletter featuring insights, trends, and news for America's Active Baby Boomers

Newsletter
New

Fda Says Ozempic And Wegovy Shortage Is Ending. That’s Bad News For This Wellness Stock.

Card image cap

“We will continue to offer access to personalized treatments as allowed by law to meet patient needs,” Hims & Hers CEO said.

Back to Listing
credit: 
Recent

  • Kirk Gibson steps away from Detroit Tigers TV booth Read More

  • The dangerous side of popular sleep and anxiety drugs like Xanax and Lorazepam Read More

  • Pepsi acquires Poppi prebiotic soda for $1.65 billion in a play to attract Gen Z Read More